EARP-1 - An Evolvable Analog Research Platform

2006 ◽  
Author(s):  
E. Ramsden ◽  
G.W. Greenwood ◽  
D. Hunter
Keyword(s):  
Research Platform

Discovery at sea; a heady mix of scientists, ships and sailors

2005 ◽  
Vol 32 (2) ◽  
pp. 177-191 ◽  
Author(s):  
A. L. Rice
Keyword(s):  
Human Nature ◽  
Research Platform ◽  
Almost All

The success or failure of science at sea depends on many factors, including the suitability of the vessel as a research platform and the support of the scientist's shipmates. This paper touches on a few of the classic examples of unsuitable ships provided for scientists and explorers, such as Wyville Thomson and Carpenter in the Lightning in 1868 and the relatively minor shortcomings of Scott's Discovery. But it concentrates on some of the personality clashes on research or exploration voyages ranging from Edmund Halley's experience of an insubordinate mate in the Paramore in 1698, to Nicolas Baudin's appalling relations with almost all of his companions in the Géographe and Naturaliste in 1800–1803. Since human nature does not change it is suggested that seagoing scientists should pay at least as much attention to the personalities of their prospective shipmates as to the characteristics of the ships in which they expect to sail.

Metadesigning Design Research - How can designers collaboratively grow a research platform

2016 ◽  
Author(s):  
◽  
Anna-Karin Arvidsson ◽  
Mikael Blomqvist ◽  
Susanne Bonja ◽  
Sara Hyltén-Cavallius ◽  
...  
Keyword(s):  
Design Research ◽  
Research Platform

scholarly journals Assessing an Electronic Health Record research platform for identification of clinical trial participants

2021 ◽  
Vol 21 ◽  
pp. 100692
Author(s):  
Niina Laaksonen ◽  
Juha-Matti Varjonen ◽  
Minna Blomster ◽  
Antti Palomäki ◽  
Tuija Vasankari ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Electronic Health Record ◽  
Health Record ◽  
Research Platform ◽  
Electronic Health ◽  
Trial Participants

Transitioning a randomized controlled trial to a digital registry – experience from the TAILOR-PCI digital follow-up study on onboarding, engagement and geofencing consent rate

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
R Avram ◽  
D So ◽  
E Iturriaga ◽  
J Byrne ◽  
R.J Lennon ◽  
...  
Keyword(s):  
Clinical Trial ◽  
The United States ◽  
Mobile App ◽  
Funding Source ◽  
Location Tracking ◽  
Main Trial ◽  
Phone Calls ◽  
Effective Manner ◽  
Research Platform

Abstract Background/Introduction TAILOR-PCI is the largest cardiovascular genotype-based randomized trial (NCT#01742117) investigating whether genotype-guided selection of oral P2Y12 inhibitor therapy improves ischemic outcomes after percutaneous coronary intervention (PCI). The TAILOR-PCI Digital Sub-Study tests the feasibility of extending original follow-up of 1 year to 2 years using state-of-the-art digital solutions. Deep phenotyping acquired during a clinical trial can be leveraged by extending follow-up in an efficient and cost-effective manner using digital technology. Purpose Our objective is to describe onboarding and engagement of participants initially recruited in a large, pragmatic, international, multi-center clinical trial to a digital registry. Methods TAILOR-PCI participants, within 23 months of their index PCI, were invited by letters containing a URL to the Digital Sub-Study website (http://tailorpci.eurekaplatform.org). These invitations were followed by phone calls, if no response to the letter, to determine reason for non-participation. A NIH-funded direct-to-participant digital research platform (the Eureka Research Platform) was used to onboard, consent and enroll participants for the digital follow-up. Participants were asked to answer health-related surveys at fixed intervals using the Eureka mobile app and desktop platform. To capture hospitalizations, participants could enable geofencing to allow background location tracking, which triggered surveys if a hospitalization was detected. Result(s) Letters were mailed to 893 of 929 eligible participants across 22 sites in the United States and Canada leading to 226 homepage visits and 118 registrations. There were 107 consents (12.0% of invited; mean age: 66.4±9.0; 19 females [18%]): 47 (44%) participants consented after the letter, 36 (34%) consented after the 1st call and 24 (22%) consented after a 2nd call. Among those who consented, 100 were eligible (7 did not have a smartphone) 81 downloaded the study mobile app and 73 agreed for geofencing (Figure 1). Among the 722 invited participants who were surveyed, 354 declined participation: due to lack of time (146; 20.2%), lack of smartphone (125; 17.3%), difficulty understanding (41; 5.7%), concern about using smartphone (34; 4.7%), concern of data privacy (14; 1.9%), concerns of location tracking (6; 0.8%) and other reasons (57; 7.9%). Conclusion Extended follow-up of a clinical trial using a digital platform is feasible but uptake in this study population was limited largely due to lack of time or a smartphone among participants. Based on data from other digital studies, uptake may also have been limited since digital follow-up consent was not incorporated at the time of consent for the main trial. Figure 1. Onboarding of the digital substudy Funding Acknowledgement Type of funding source: Public grant(s) – National budget only. Main funding source(s): National Institute of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

scholarly journals TSD: A Research Platform for Sensitive Data

2021 ◽  
Vol 181 ◽  
pp. 127-134
Author(s):  
Egil Øvrelid ◽  
Bendik Bygstad ◽  
Gard Thomassen
Keyword(s):  
Sensitive Data ◽  
Research Platform
Sign in / Sign up

Export Citation Format

Share Document